List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 30 studies with search of: Abatacept for Rheumatoid Arthritis
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed
Has Results 		A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis, With an Inadequate Response to Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Methotrexate;   Drug: Placebo
2 Recruiting Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs
Condition: Rheumatoid Arthritis
Intervention: Biological: Venous blood sample
3 Active, not recruiting Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Abatacept
4 Active, not recruiting BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
5 Recruiting Efficacy, Pharmacokinetics, Safety and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japan
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
6 Active, not recruiting A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Abatacept
7 Completed Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
8 Completed A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
9 Active, not recruiting A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Condition: Rheumatoid Arthritis, NOS
Interventions: Drug: Abatacept;   Drug: placebo
10 Active, not recruiting Phase IIIB Subcutaneous Missed Dose Study
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
11 Completed Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Belatacept;   Drug: Abatacept
12 Completed
Has Results 		Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients
Condition: Arthritis, Rheumatoid
Interventions: Drug: Abatacept;   Drug: placebo
13 Completed Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept + Methotrexate;   Drug: Infliximab + Methotrexate;   Drug: Placebo + Methotrexate;   Drug: Abatacept
14 Completed Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
Condition: Rheumatoid Arthritis
Intervention: Drug: Abatacept
15 Recruiting A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography
Condition: Rheumatoid Arthritis
Intervention: Drug: Abatacept
16 Completed An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy
Condition: Rheumatoid Arthritis
Intervention: Drug: Abatacept
17 Recruiting Abatacept Versus Adalimumab Head-to-Head
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Adalimumab
18 Completed A Phase III Study of BMS-188667 in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: BMS-188667;   Drug: Methotrexate;   Drug: Placebo
19 Completed A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Placebo
20 Recruiting Methotrexate-Inadequate Response Study
Condition: Rheumatoid Arthritis (RA)
Interventions: Drug: Abatacept subcutaneous + placebo IV;   Drug: Abatacept IV + placebo subcutaneous

Previous Page Studies Shown (1-20) Next Page (21-30)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services